Preferences of healthy men for two different endocrine treatment options offered for locally advanced prostate cancer.

Abstract:

OBJECTIVE:The aim of this study was to determine whether healthy men would prefer either luteinizing hormone releasing hormone analogues (LHRHa) or non-steroidal anti-androgen therapy (NSAA) should they hypothetically develop locally advanced prostate cancer. PARTICIPANTS AND METHODS:A representative sample of 180 men without prostate cancer (68% over 65 years of age, range 50-90 years), read two scenarios describing LHRHa or NSAA treatments for locally advanced prostate cancer. Participants chose which drug treatment they hypothetically would prefer, gave a reason for their choice and indicated the degree to which they wanted to avoid side effects specific to each drug. RESULTS:Eighty-six per cent (156/180) of the men chose NSAA therapy, 7% (12/180) chose LHRHa therapy and 7% (12/180) could not decide. The main reason men chose LHRHa therapy was because of the method of administration (9/12) whereas those who chose NSAA therapy cited avoidance of the side effects associated with LHRHa treatment (115/156). The side effects, ranked in order of importance, that men who chose NSAA therapy most wanted to avoid included risk of potential fractures (85%), reduced physical strength (76%), decreased sexual interest (56%), impotence (51%), hot flushes (49%), breast enlargement (17%) and breast tenderness (13%). CONCLUSION:Although this project was a hypothetical study, several important issues emerged from the data that are relevant to patient choice. Men should be fully informed about the side-effect profiles of different endocrine treatments, involved in decision making and allowed to choose therapies less likely to cause side effects they would prefer to avoid.

journal_name

Curr Med Res Opin

authors

Jenkins V,Fallowfield L,Edginton T,Payne H,Hamilton E

doi

10.1185/030079905X59058

keywords:

subject

Has Abstract

pub_date

2005-09-01 00:00:00

pages

1329-35

issue

9

eissn

0300-7995

issn

1473-4877

journal_volume

21

pub_type

杂志文章
  • The economic impact of blue-light filtering intraocular lenses on age-related macular degeneration associated with cataract surgery: a third-party payer's perspective.

    abstract:OBJECTIVES:Epidemiological data support an association between age-related macular degeneration (AMD) and cataract surgery that may be attributed to post-operative blue light exposure. By limiting the retina's blue light exposure, new blue-light filtering intraocular lenses (BLF IOLs) have the potential to reduce the d...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X115586

    authors: Reddy P,Gao X,Barnes R,Fairchild C,Boci K,Waycaster C,Pashos C

    更新日期:2006-07-01 00:00:00

  • Influence of intraoperative remifentanil and sufentanil on sensory perception: a randomized trial.

    abstract:OBJECTIVE:The clinical relevance of pro- and hyperalgesic effects of opioids is still a matter of debate. Particularly for remifentanil, an increased postoperative need for analgesics has been demonstrated suggesting opioid-induced hyperalgesia as a possible cause. The aim of the study was therefore to investigate the ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1080/03007995.2016.1211517

    authors: Ohnesorge H,Alpes A,Baron R,Gierthmühlen J

    更新日期:2016-11-01 00:00:00

  • Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.

    abstract:OBJECTIVES:Compare costs and healthcare resource utilization (HCRU) among newly-diagnosed non-valvular atrial fibrillation (NVAF) patients newly treated with dabigatran vs apixaban, rivaroxaban, or warfarin. METHODS:Newly-diagnosed adult NVAF patients initiating dabigatran, apixaban, rivaroxaban, or warfarin (index ev...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1409425

    authors: Gilligan AM,Franchino-Elder J,Song X,Wang C,Henriques C,Sainski-Nguyen A,Wilson K,Smith DM,Sander S

    更新日期:2018-02-01 00:00:00

  • Six-day clotrimazole therapy in vaginal candidosis.

    abstract::Two hundred and two patients with symptoms, signs and mycological evidence of Candida vaginitis were entered in a single-blind trial comparing 6-day clotrimazole therapy with a control group receiving 6 days' nystatin therapy. Adequate data was collected on 69 clotrimazole and 72 nystatin treated patients for analysis...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997509113652

    authors: Masterton G,Henderson J,Napier IR,Moffet M

    更新日期:1975-01-01 00:00:00

  • The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.

    abstract:BACKGROUND:The rising prevalence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) and the recent emergence of community-associated MRSA are major clinical, public health, and economic challenges. MRSA is a leading cause of nosocomial pneumonia and complicated skin and soft-tissue infections (cSSTI). Van...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990903512057

    authors: Stein GE,Wells EM

    更新日期:2010-03-01 00:00:00

  • Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.

    abstract:OBJECTIVE:The Glucose and Lipid Assessment in Diabetes (GLAD) trial examined the dose-response relationship of the dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist tesaglitazar in type 2 diabetic patients. STUDY DESIGN:GLAD was a 12-week, multicenter, international, randomized, parallel-group...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079906x154169

    authors: Goldstein BJ,Rosenstock J,Anzalone D,Tou C,Ohman KP

    更新日期:2006-12-01 00:00:00

  • An examination of surgical and survival outcomes in the elderly (65-79 years of age) and the very elderly (≥80 years of age) who received surgery for gastric cancer.

    abstract::Objective: The purpose of this study was to examine surgical and survival outcomes in the elderly (65-79 years of age) and the very elderly (≥80 years of age) who received surgery for gastric cancer.Methods: This study retrospectively reviewed the records of patients ≥65 years old who received a gastrectomy for gastri...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2018.1520083

    authors: Wong JU,Tai FC,Huang CC

    更新日期:2020-02-01 00:00:00

  • Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.

    abstract:OBJECTIVE:To test the hypothesis that first-line treatment with atomoxetine provides superior efficacy than placebo for up to 12 weeks in improving the symptoms of Attention Deficit/Hyperactivity Disorder (ADHD). RESEARCH DESIGN AND METHODS:This double-blind, randomized, placebo-controlled, parallel clinical trial inc...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007990903316152

    authors: Montoya A,Hervas A,Cardo E,Artigas J,Mardomingo MJ,Alda JA,Gastaminza X,García-Polavieja MJ,Gilaberte I,Escobar R

    更新日期:2009-11-01 00:00:00

  • Towards a better understanding of postprandial hyperglycemic episodes in people with diabetes: impact on daily functioning.

    abstract:OBJECTIVE:Acute postprandial hyperglycemia (aPPHG) is often symptomatic and can be associated with behavioral changes such as impaired working memory and attention. However, there is little evidence of the impact of aPPHG on the daily lives of patients. The aim of this study was to explore the frequency and severity of...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2018.1525344

    authors: Heller S,Meneghini L,Nikolajsen A,Kragh N,Lewis HB,Saretsky T,Kosmas CE,Lloyd A

    更新日期:2019-03-01 00:00:00

  • Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.

    abstract:OBJECTIVE:To compare glycemic goal achievement (HbA(1c) < 7%) in type 2 diabetes patients receiving initial metformin plus pioglitazone combination therapy and initial metformin monotherapy augmented with pioglitazone in a cohort follow-up study. RESEARCH DESIGN AND METHODS:Adult patients were identified from the Inge...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.536755

    authors: Pandya BJ,Bron M,McCall T,Yu AP,Chen KS,Mattson ME,Wu EQ

    更新日期:2011-01-01 00:00:00

  • Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.

    abstract:BACKGROUND:Reducing low-density lipoprotein cholesterol (LDL-C) levels to National Cholesterol Expert Panel (NCEP) goal is recommended. However, sex-specific effects may influence benefit. METHODS AND RESULTS:In this post hoc analysis of the GREek Atorvastatin and Coronary heart disease (CHD) Evaluation [GREACE] study...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007990802069563

    authors: Athyros VG,Kakafika AI,Papageorgiou AA,Paraskevas KI,Tziomalos K,Anagnostis P,Pagourelias E,Koumaras C,Karagiannis A,Mikhailidis DP

    更新日期:2008-06-01 00:00:00

  • Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trial.

    abstract:OBJECTIVES:Chronic obstructive pulmonary disease (COPD) is becoming a leading cause of morbidity and mortality in China. In the IMPACT trial, fluticasone furoate[FF]/umeclidinium[UMEC]/vilanterol[VI] single-inhaler triple therapy demonstrated lower rates of moderate/severe exacerbations than dual therapy with FF/VI or ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1844646

    authors: Zheng J,Zhong N,Wang C,Wei LP,Zhou XD,Zhao L,Dong Yuan Y,He B,Wu B,Du X,Song J,Lipson DA

    更新日期:2021-01-01 00:00:00

  • Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.

    abstract::Doxofylline (7-(1,3-dioxalan-2-ylmethyl) theophylline) is a novel xanthine bronchodilator which differs from theophylline in that it contains a dioxalane group in position 7. Similarly to theophylline, its mechanism of action is related to the inhibition of phosphodiesterase activities, but in contrast it appears to h...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079901750120196

    authors: Dini FL,Cogo R

    更新日期:2001-01-01 00:00:00

  • Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden.

    abstract:OBJECTIVES:The objective of this study was to analyze the characteristics and costs of exogenous endoscopy-related infections, pseudo-infections, and toxic reactions in the US. METHODS:A systematic review of the scientific literature published between 1966 and 2005 was conducted in Medline. Data collection was based o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079906X121048

    authors: Seoane-Vazquez E,Rodriguez-Monguio R,Visaria J,Carlson A

    更新日期:2006-10-01 00:00:00

  • Elevation of high density lipoprotein cholesterol (cHDL) and reduction of the total cholesterol/cHDL index in the treatment of hyperlipoproteinaemias IIb and IV with bezafibrate.

    abstract::A study was carried out in 21 patients with Type IIb or Type IV hyperlipoproteinaemia to evaluate the effect of treatment with 600 mg bezafibrate per day over a period of 3 months. The results of the lipid parameters studied showed that there were significant reductions after 1 and 3-months' treatment, respectively, o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998309112398

    authors: Neuman MP,Kurlat MI,Neuman J

    更新日期:1983-01-01 00:00:00

  • Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.

    abstract::Objectives Real-world patient outcomes data is scarce concerning the high disease burden of IBS-C. The aim of this study was to compare patient-reported symptom control, health-related quality of life (HRQoL), resource utilization, and treatment satisfaction of lubiprostone vs non-lubiprostone treatment for irritable ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2016.1150262

    authors: Solem CT,Patel H,Mehta S,Mody R,Macahilig C,Gao X

    更新日期:2016-05-01 00:00:00

  • Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.

    abstract:OBJECTIVE:To report the long-term effect of the dorzolamide/timolol (DTFC) and latanoprost/timolol (LTFC) fixed combinations on intraocular pressure (IOP) and visual field defects over time in naïve primary open-angle glaucoma (POAG) patients. STUDY DESIGN AND METHODS:Prospective, 4-year, open-label, interventional st...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007995.2010.508702

    authors: Pajic B,Pajic-Eggspuehler B,Häfliger IO

    更新日期:2010-09-01 00:00:00

  • Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis.

    abstract:BACKGROUND:As results from an increasing number of clinical trials with disease-modifying drugs (DMDs) in multiple sclerosis (MS) become available, the challenge for the treating neurologist is how to decide on the appropriate therapy for an individual patient. OBJECTIVE:An International Working Group for Treatment Op...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007x233007

    authors: Goodin DS,Biermann LD,Bohlega S,Boiko A,Chofflon M,Gebeily S,Gouider R,Havrdova E,Jakab G,Karabudak R,Karussis D,Miller A,Pakdaman H,Selmaj K,Sharief M,International Working Group for Treatment Optimization in MS.

    更新日期:2007-11-01 00:00:00

  • The treatment of tennis elbow with triamcinolone acetonide.

    abstract::Twenty-seven patients with tennis elbow were treated with triamcinolone acetonide (40 mg/ml) injected locally into the tender area without local anaesthetic. Reduction of pain or complete relief was achieved in 1 to 72 hours, although in 9 cases exacerbation of pain occurred before relief was given. The recurrence rat...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998009109477

    authors: Nevelös AB

    更新日期:1980-01-01 00:00:00

  • Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.

    abstract:OBJECTIVE:To evaluate intraocular pressure (IOP)-lowering efficacy, tolerability, and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% (Ganfort) among German patients. METHODS:Multicenter, observational, open-label study of patients with primary open angle glaucoma or ocular hypertension (n = 606)...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990902816947

    authors: Feuerhake C,Buchholz P,Kimmich F

    更新日期:2009-04-01 00:00:00

  • A comparison of an antacid plus antispasmodic combination and aluminium hydroxide in dyspepsia.

    abstract::A single-blind, between-patient comparative study was carried out in general practice to assess the effectiveness of antacid plus antispasmodic combination tablets (240 mg dried aluminium hydroxide B.P., 144 mg magnesium hydroxide B.P.C., and 5 mg dicyclomine hydrochloride B.P.) and aluminium hydroxide B.P. tablets (5...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997709110165

    authors: Kagan G,Rose R

    更新日期:1977-01-01 00:00:00

  • A novel application for bolus remifentanil: blunting the hemodynamic response to Mayfield skull clamp placement.

    abstract:OBJECTIVE:Neurosurgery often requires skull immobilization with a Mayfield clamp, which often causes brief intense nociceptive stimulation, hypertension and tachycardia. Blunting this response may help prevent increased intracranial pressure, cerebral aneurysm or vascular malformation rupture, and/or myocardial stress....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.855190

    authors: Berger M,Philips-Bute B,Guercio J,Hopkins TJ,James ML,Borel CO,Warner DS,McDonagh DL

    更新日期:2014-02-01 00:00:00

  • Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.

    abstract:PURPOSE:To compare the efficacy and safety of the concomitant administration of travoprost 0.004% once daily and brinzolamide 0.1% twice daily with those of a fixed combination of latanoprost 0.005%/timolol 0.5% once daily. RESEARCH, DESIGN AND METHODS:Forty-four patients with primary open-angle glaucoma or ocular hyp...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/030079904125004529

    authors: Martinez-de-la-Casa JM,Castillo A,Garcia-Feijoo J,Mendez-Hernandez C,Fernandez-Vidal A,Garcia-Sanchez J

    更新日期:2004-09-01 00:00:00

  • Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.

    abstract:OBJECTIVE:The dopamine agonist rotigotine has shown efficacy and safety for the treatment of early and advanced Parkinson's disease (PD) in controlled clinical trials. This observational study evaluated rotigotine administration in combination with other antiparkinsonian medication in routine clinical practice. METHOD...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/03007995.2011.611630

    authors: Ceballos-Baumann A,Häck HJ

    更新日期:2011-10-01 00:00:00

  • Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trial.

    abstract::An open, multi-centre trial was carried out to assess the efficacy and tolerance of acemetacin in the treatment of patients suffering from various rheumatic diseases. The patients were treated by general practitioners for a maximum period of 6 weeks with a daily dose of 60 mg acemetacin 3-times daily. Assessments were...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007998509109654

    authors: Rechziegler H,Zündorf P

    更新日期:1985-01-01 00:00:00

  • Systemic side-effects of three topical steroids in diseased skin.

    abstract::Two clinical trials were carried out in order to study adrenal suppression in 6 patients with psoriatic erythroderma and in 28 patients with psoriasis treated with topical glucocorticosteroids. Betamethasone-17-valerate (0.1%), betamethasone-17,21-dipropionate (0.05%) and budesonide (0.025%) ointments were studied in ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007998309109785

    authors: Salde L,Lassus A

    更新日期:1983-01-01 00:00:00

  • Individualized chemotherapy based on organ selectivity: a retrospective study of vinorelbine and capecitabine for patients with metastatic breast cancer.

    abstract:OBJECTIVES:This study proposed a conception of individualized chemotherapy based on organ selectivity of drug distribution by retrospectively comparing the effect of vinorelbine and capecitabine in patients with metastatic breast cancer. METHODS:Between January 2002 and December 2009, 133 patients with lung metastasis...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.895310

    authors: Liu XH,Man YN,Cao R,Liu C,Wu XZ

    更新日期:2014-06-01 00:00:00

  • Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.

    abstract:OBJECTIVE:To investigate if combined intraocular pressure (IOP)-lowering medication with travoprost/timolol fixed combination and a carbonic anhydrase inhibitor, brinzolamide, is superior to both travoprost monotherapy and travoprost/timolol fixed-combination therapy in primary open-angle glaucoma and ocular hypertensi...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007990802159273

    authors: Holló G,Kóthy P

    更新日期:2008-06-01 00:00:00

  • Ways to increase adherence to allergen immunotherapy.

    abstract::Adherence to allergen immunotherapy (AIT) is crucial for its efficacy. Subcutaneous AIT requires monthly visits (or more extended in the case of venom immunotherapy), while sublingual AIT is performed with a daily intake of allergen drops. Non-adherence to an AIT schedule and premature discontinuation are common probl...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2018.1552044

    authors: Pitsios C,Dietis N

    更新日期:2019-06-01 00:00:00

  • Venous thromboembolism: identifying patients at risk and establishing prophylaxis.

    abstract::Venous thromboembolism (VTE) is a major cause of morbidity and mortality and is associated with substantial healthcare costs. Identification of patients at risk of developing VTE enables appropriate thromboprophylaxis to be implemented. Although no predisposing risk factors can be identified in many patients in whom V...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1098599

    authors: Shirvanian S,Tapson VF

    更新日期:2015-12-01 00:00:00